TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

360 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicPeptide & GLP-1Mental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

136 studies on the map

Exercise Neuroprotection in Parkinson's Disease — Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV, Las VegasEvaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity — University of Connecticut, StorrsParkinson's Foundation PD GENEration Genetic Registry — University of Alabama Birmingham, BirminghamDaily Amino Acid Supplementation for People With Parkinson's Disease — University of Connecticut, StorrsTargeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial — Sidney & Lois Eskenazi Hospital, IndianapolisTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD — Arizona State University, TempePhase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments — Domino's Farms, Ann ArborEffects of RAS on Gait in PD Patients With DBS — Johns Hopkins School of Medicine, BaltimoreVirtual tES Device Treatment for Parkinson's Disease Motor Symptoms — U LLC Headquarters, ClevelandSleep-specific DBS Therapy in Parkinson's Disease — University Of Minnesota, MinneapolisCortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing — Oregon Health and Science University, PortlandEffects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease — The Regenesis Project, Santa MonicaTargeted Motor Learning to Improve Gait for Individuals With Parkinson Disease — University of North Carolina at Chapel Hill, Chapel HillColonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder — Digestive Disease Associates, BranfordClinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — Johns Hopkins, BaltimoreA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestChanges in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs — University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El PasoPrescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults — Kennesaw State Universityh, KennesawA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Banner Sun Health Research Institute, Sun CityEffects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients — NYIT College of Osteopathic Medicine, Old WestburySafety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial — AARA Clinical Research, GlendaleA Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery — University of Kentucky, LexingtonModerate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease — Atlanta VA Medical and Rehab Center, Decatur, GA, DecaturApathy in Parkinson Disease TMS Study — UNC-Chapel Hill, Cassidy Lab, Chapel HillA Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors — UConn Health, FarmingtonCharacterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. — University of Minnesota, MinneapolisA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Investigative Site, Beverly HillsEvaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaSegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease — University of Texas Southwestern Medical Center, DallasA Study of Buntanetap in Participants With PD — University of Alabama at Birmingham, BirminghamPET Imaging Evaluation of [11C]SY08 — MGH, CharlestownCD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus — Children's Hospital of Philadelphia, PhiladelphiaUS Zamto-cel Autoimmune Diseases — Froedtert Hospital and the Medical College of Wisconsin, MilwaukeeDapagliflozin in Active Lupus Nephritis — Massachusetts General Hospital, BostonA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications — Banner Alzheimer's Institute (BAI)-Phoenix, PhoenixImpact of a Biophoton Therapy on Patients With Brain Disorders — Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, ButlerA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) — Inland Rheumatology Clinical Trials, Inc., UplandFeasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease — Richmond VA Medical Center, Richmond, VA, RichmondA Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease — Research Site 4, Redwood CityEvaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies — Institute for Neurodegenerative Disorders and XingImaging, LLC, New HavenStriatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation — University of Michigan, Ann ArborA Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease — Banner Sun Health Research Institute, Sun CityA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Barrow Neurological Institute, PhoenixSocial & QoL Behaviors in Parkinson's Disease — The George Washington University, Washington D.C.Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease — University of California San Francisco, San FranciscoA Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 — University of Colorado, Denver, DenverGenetics and Aerobic Exercise to Slow Parkinson's Disease Trial — The Cleveland Clinic, ClevelandA Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) — Climb Bio Investigative Site #100104, AllenSpeech Learning and Speech Production in Parkinson's Disease — State University of New York at Buffalo, BuffaloSpinal Cord Stimulation for Parkinson's Disease Rehabilitation — Frazier Rehab Institute, LouisvilleA Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) — Wallace & Lee Center, Beverly HillsOptimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease — Louis Stokes VA Medical Center, Cleveland, OH, ClevelandSystemic Lupus Erythematosus in Gullah Health — Medical University of South Carolina, CharlestonResearch Accelerated by You Lupus Registry — Online Registry - No Physical Site Required, Washington D.C.Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting — University of Florida, GainesvilleCutaneous Lupus Registry — University of Texas Southwestern Medical Center Dallas, DallasA Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) — University of Colorado Anschutz Medical Campus, AuroraEndurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD — UT Health San Antonio- Dept. of Physical Therapy, San AntonioStereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor — Vanderbilt University Medical Center, NashvilleRegistry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Neurology and Pain Specialty, Aliso ViejoA Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — Local Institution - 0062, MesaModifiable Variables in Parkinsonism (MVP) — Bastyr University, KenmoreColonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis — Oregon Health & Science University, PortlandBrief Pain Exposure Therapy (BPET) For Nociplastic Pain — University of Michigan, Ann ArborMaternal Autoimmune Disease Research Alliance (MADRA) Registry — Duke University, DurhamEffects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease — Movement Disorders Laboratory, MinneapolisTrial of Belimumab in Early Lupus — Feinstein Institute, ManhassetThe Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study — University of California, San Francisco, San FranciscoOpen-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease — Invicro (dba Perceptive), New HavenAdaptive DBS to Offset STN Dysregulation During Exercise in PD — University of Colorado, AuroraA Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease — Wallace Rheumatic Center, Beverly HillsRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus — University of California Irvine, OrangePhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Pinnacle Research Group Llc, AnnistonGlobus Pallidus Stimulation to Treat Insomnia — Mayo Clinic in Florida, JacksonvilleRheumatology Diet Study — UCF Health Clinics, OrlandoBAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus — Nationwide Children's, ColumbusStudy in Parkinson Disease of Exercise — University of Alabama at Birmingham, BirminghamStimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD — University of Alabama at Birmingham, BirminghamThe BRIDGE Pain Study — Cincinnati Children's Hospital, CincinnatiPRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis — Purushotham & Akther Kotha MD, Inc., La MesaPercept Transitions in FOG and PD — University of Minnesota, Movement Disorders Lab, MinneapolisRemote Haptic Rehabilitation for Parkinson's Disease — Virginia Tech, BlacksburgCottonseed Oil Versus Matched PUFA Effects — University of Georgia, AthensOnline Motor Control in People With Parkinson's Disease — University of Delaware, NewarkImaging Depression in Parkinson's Disease — Yale University, New HavenZesty Exercise System for Therapeutic Engagement — Emory University, 57 Executive Park S NE, Ste 200, AtlantaA Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Collaborative Neuroscience Network - CNS, Los AlamitosEffects of Stopping Hydroxychloroquine in Elderly Lupus Disease — University of California, Los Angeles, Los AngelesA Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) — GSK Investigational Site, AnnistonKetamine for Veterans With Parkinson's Disease — San Francisco VA Medical Center, San Francisco, CA, San FranciscoA Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE — Research Site, San FranciscoA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) — Life Clinical Trials - Colonial Drive - Margate /ID# 276050, MargateSAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Rocky Mountain Clinical Research, EnglewoodNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkVirtual Cycling Environments for Persons With Parkinson Disease — School of Health Professions, NewarkA Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment — Alloy Clinical Research LLC, KissimmeeEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — Institute for Neurodegenerative Disorders, New HavenAdapting rHIRE and Sleep Monitoring in Parkinson's Disease — University of Colorado Anschutz Medical Campus, AuroraEvaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease — University of Colorado Anschutz, AuroraPsilocybin Therapy for Depression in Parkinson's Disease — University of California, San Francisco, San FranciscoIntervention to Improve Communication and Medication Adherence in Lupus — Duke University, DurhamTransforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus — University of Alabama Birmingham Hospital, BirminghamAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2) — University of Nebraska Medical Center, OmaharTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease — West Virginia University Hospitals, MorgantownA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants — Loma Linda University health, Loma LindaREACT-01: Reversing Autoimmunity Through Cell Therapy — Seattle Children's Hospital, SeattleIdentification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder — University of Minnesota, MinneapolisCortical Electrophysiology of Response Inhibition in Parkinson's Disease — Emory University Hospital, AtlantaLow Voltage Electrical Stimulation for Depression in Parkinson's Patients — University of South Alabama, MobileAlnuctamab for Refractory SLE (LATTE Study) — Icahn School of Medicine at Mount Sinai, New YorkReal-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: — Parkinson's Disease and Movement Disorders Center - Orange County (South), Aliso ViejoPharmacy-led Transitions of Care Intervention to Improve Medication Adherence — University of Tennessee Medical Center, KnoxvillePhase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders — MD Anderson Cancer Center, HoustonInvestigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients — Boston University, BostonVestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease — University of Minnesota, Movement Disorders Lab, MinneapolisInspire HER: Inspiring the Heart and Emotions for Radical Health — University of Alabama at Birmingham, BirminghamBlood Flow Restriction for Optimizing Balance in Parkinson's Disease — University of Texas Health Science Center at San Antonio, San AntonioIntermittent Cottonseed Oil Consumption — University of Georgia, AthensStudy to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN — GSK Investigational Site, BaltimoreA Pilot Study of In-lab Dynamic Standing in Parkinson's Disease — Domino's Farms, Ann ArborSafety and Usability of the Cionic Neural Sleeve for Parkinson's Disease — Adapt Movement, CarlsbadFirst-in-Human Single and Multiple Dose of HL-400 — Pharmaron CPC, Inc., BaltimoreEffects of an Independent Walking Program With Walking Poles in People With Parkinson Disease — East Tennessee State University, Johnson CityImaging Core Aim 2, and Udall Project 2 Aim 2 — University of Minnesota, MinneapolisA Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) — Mayo Clinic, PhoenixThe Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD — National Institutes of Health Clinical Center, BethesdaLow-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease — Quest Research Institute, Farmington HillsDance and Energy Expenditure Among Adults With Parkinson's — Northeastern University, BostonUsing taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease — Wellness, Health and Research Facility at UAB, BirminghamDrug Discovery for Parkinson's With Mutations in the GBA Gene — The New York Stem Cell Foundation Research Institute, New YorkSafety of the Herpes Zoster Subunit Vaccine in Lupus — NYU Langone Health, New YorkGonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires — National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), BethesdaNeuroimaging of Parkinson's — East Imaging Building, St LouisLongitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging) — UAB, BirminghamDirect to Patient Minimal Risk Biospecimen and Data Collection Research — Joined Bio, LexingtonInterprofessional Pharmacogenomics (IPGx) Registry and Repository — Texas A&M Family Care, Bryan

Showing the 150 nearest — narrow your filters for fewer, closer studies.